1-15 of 15
M. Scott Lucia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2980: MIRO2/GCN1/ATF4 retrograde signaling modulates prostate cancer growth and invasion

Madison Furnish, Dillon Boulton, Victoria Genther, Denisa Grofova, Mitchell L. Ellinwood, Lina Romero, M. Scott Lucia, Scott D. Cramer, M. Cecilia Caino
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2980.
https://doi.org/10.1158/1538-7445.AM2022-2980
Published: 15 June 2022
View article titled, Abstract 2980: MIRO2/GCN1/ATF4 retrograde signaling modulates prostate cancer growth and invasion
Journal Articles

Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer

Adam C. Mueller, Miles Piper, Andrew Goodspeed, Shiv Bhuvane, Jason S. Williams, Shilpa Bhatia, Andy V. Phan, Benjamin Van Court, Kathryn L. Zolman, Brisa Peña, Ayman J. Oweida, Sara Zakem, Cheryl Meguid, Michael W. Knitz, Laurel Darragh, Thomas E. Bickett, Jacob Gadwa, Luisa Mestroni, Matthew R.G. Taylor, Kimberly R. Jordan, Peter Dempsey, M. Scott Lucia, Martin D. McCarter, Marco Del Chiaro, Wells A. Messersmith, Richard D. Schulick, Karyn A. Goodman, Michael J. Gough, Casey S. Greene, James C. Costello, Antonio Galveo Neto, David Lagares, Kirk C. Hansen, Adrie Van Bokhoven, Sana D. Karam
Journal: Cancer Research
Cancer Res (2021) 81 (12): 3255–3269.
https://doi.org/10.1158/0008-5472.CAN-20-3892
Published: 15 June 2021
View article titled, Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer
Open the PDF for Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 1580: Distinct pathways of lytic and blastic bone metastases in prostate cancer patients

Claire L. Ihle, Meredith D. Provera, Desiree M. Straign, E. Erin Smith, Susan M. Edgerton, Adrie Van Bokhoven, M. Scott Lucia, Philip Owens
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1580.
https://doi.org/10.1158/1538-7445.AM2020-1580
Published: 15 August 2020
View article titled, Abstract 1580: Distinct pathways of lytic and blastic bone metastases in prostate cancer patients
Journal Articles

Abstract A52: Gene alterations associated with clinical characteristics of bladder cancer

Mike Nickerson, Kate M. Im, Guangwu Guo, Yaoting Gui, Sevilay Turan, James C. Costello, Quan Zhou, Zhiming Cai, Song Wu, M. Scott Lucia, Lee E. Moore, Michael Dean, Dan Theodorescu
Journal: Cancer Research
Cancer Res (2016) 76 (2_Supplement): A52.
https://doi.org/10.1158/1538-7445.CHROMEPI15-A52
Published: 14 January 2016
View article titled, Abstract A52: Gene alterations associated with clinical characteristics of bladder cancer
Journal Articles

Abstract 4605: Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Danyelle A. Winchester, Cathee Till, Phyllis J. Goodman, Catherine M. Tangen, Regina M. Santella, Teresa L. Johnson-Pais, Robin J. Leach, Jianfeng Xu, S. Lilly Zheng, Ian M. Thompson, M. Scott Lucia, Scott M. Lippmann, Howard L. Parnes, Paul J. Dluzniewski, William B. Isaacs, Angelo M. De Marzo, Charles G. Drake, Elizabeth A. Platz
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4605.
https://doi.org/10.1158/1538-7445.AM2015-4605
Published: 01 August 2015
View article titled, Abstract 4605: Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial
Journal Articles

Coordinate Loss of MAP3K7 and CHD1 Promotes Aggressive Prostate Cancer

Lindsey Ulkus Rodrigues, Leah Rider, Cera Nieto, Lina Romero, Anis Karimpour-Fard, Massimo Loda, M. Scott Lucia, Min Wu, Lihong Shi, Adela Cimic, S. Joseph Sirintrapun, Rosalie Nolley, Colton Pac, Haitao Chen, Donna M. Peehl, Jianfeng Xu, Wennuan Liu, James C. Costello, Scott D. Cramer
Journal: Cancer Research
Cancer Res (2015) 75 (6): 1021–1034.
https://doi.org/10.1158/0008-5472.CAN-14-1596
Published: 12 March 2015
View article titled, Coordinate Loss of <em>MAP3K7</em> and <em>CHD1</em> Promotes Aggressive Prostate Cancer
Open the PDF for Coordinate Loss of <em>MAP3K7</em> and <em>CHD1</em> Promotes Aggressive Prostate Cancer in another window
Journal Articles

Abstract 1863: Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results from the Prostate Cancer Prevention Trial

Douglas K. Price, Cindy H. Chau, William D. Figg, Catherine A. Till, Phyllis J. Goodman, Yonggon Cho, Marileila Garcia, Juergen Reichardt, Catherine M. Tangen, Robin J. Leach, Adrie van Bokhoven, Alan R. Kristal, Ian M. Thompson, M Scott Lucia
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1863.
https://doi.org/10.1158/1538-7445.AM2014-1863
Published: 01 October 2014
View article titled, Abstract 1863: Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results from the Prostate Cancer Prevention Trial
Journal Articles

Hedgehog Signaling Alters Reliance on EGF Receptor Signaling and Mediates Anti-EGFR Therapeutic Resistance in Head and Neck Cancer

Stephen B. Keysar, Phuong N. Le, Ryan T. Anderson, J. Jason Morton, Daniel W. Bowles, Jeramiah J. Paylor, Brian W. Vogler, Jackie Thorburn, Pamela Fernandez, Magdalena J. Glogowska, Sarah M. Takimoto, Daniel B. Sehrt, Gregory N. Gan, Justin R. Eagles-Soukup, Hilary Serracino, Fred R. Hirsch, M. Scott Lucia, Andrew Thorburn, John I. Song, Xiao-Jing Wang, Antonio Jimeno
Journal: Cancer Research
Cancer Res (2013) 73 (11): 3381–3392.
https://doi.org/10.1158/0008-5472.CAN-12-4047
Published: 30 May 2013
View article titled, Hedgehog Signaling Alters Reliance on EGF Receptor Signaling and Mediates Anti-EGFR Therapeutic Resistance in Head and Neck Cancer
Open the PDF for Hedgehog Signaling Alters Reliance on EGF Receptor Signaling and Mediates Anti-EGFR Therapeutic Resistance in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract #4510: A pilot study of oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer

Thomas Flaig, L. Michael Glode, Daniel Gustafson, Adrie van Bokhoven, Yuzhen Tao, Shandra Wilson, Lih-Jen Su, Yuan Li, Gail Harrison, Rajesh Agarwal, E. David Crawford, M. Scott Lucia, Michael Pollak
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4510.
Published: 01 May 2009
View article titled, Abstract #4510: A pilot study of oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer
Journal Articles

Abstract #5051: Prostate derived factor: A modulator of prostatic inflammation and tumorigenesis?

Ramon Whitson, Julie Kelly, Erin Genova, Francisco LaRosa, Jenny Parvani, M. Scott Lucia, James Lambert
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5051.
Published: 01 May 2009
View article titled, Abstract #5051: Prostate derived factor: A modulator of prostatic inflammation and tumorigenesis?
Journal Articles

Abstract #4327: Gene fusions in prostate carcinoma cell lines: An investigation by fluorescence in situ hybridization (FISH)

Margaret Skokan, Sujatha Gajapathy, L. Michael Glode, M. Scott Lucia, Marileila Varella-Garcia, Adrie van Bokhoven
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4327.
Published: 01 May 2009
View article titled, Abstract #4327: Gene fusions in prostate carcinoma cell lines: An investigation by fluorescence in situ hybridization (FISH)
Journal Articles

2-Methoxyestradiol induced prevention of prostate tumors: Enhancing its efficacy

Addanki P. Kumar, M Scott Lucia, Gretchen E. Garcia, Nicole Arevalo, Daniel E. Chan, Natasha Kyprianou, Susan L. Kraft, Hans-Georg Wisniewski, Rita Ghosh
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1227–1228.
Published: 01 May 2005
View article titled, 2-Methoxyestradiol induced prevention of prostate tumors: Enhancing its efficacy
Journal Articles

Aberrant HOXC Expression Accompanies the Malignant Phenotype in Human Prostate

Gary J. Miller, Heidi L. Miller, Adrie van Bokhoven, James R. Lambert, Priya N. Werahera, Osvaldo Schirripa, M. Scott Lucia, Steven K. Nordeen
Journal: Cancer Research
Cancer Res (2003) 63 (18): 5879–5888.
Published: 01 October 2003
View article titled, Aberrant <em>HOXC</em> Expression Accompanies the Malignant Phenotype in Human Prostate
Open the PDF for Aberrant <em>HOXC</em> Expression Accompanies the Malignant Phenotype in Human Prostate in another window
Journal Articles

Chemopreventive Activity of Tamoxifen, N-(4-Hydroxyphenyl)retinamide, and the Vitamin D Analogue Ro24-5531 for Androgen-promoted Carcinomas of the Rat Seminal Vesicle and Prostate

M. Scott Lucia, Mario A. Anzano, Michael V. Slayter, Miriam R. Anver, Darlene M. Green, Mark W. Shrader, Daniel L. Logsdon, Craig L. Driver, Charles C. Brown, Christopher W. Peer, Anita B. Roberts, Michael B. Sporn
Journal: Cancer Research
Cancer Res (1995) 55 (23): 5621–5627.
Published: 01 December 1995
View article titled, Chemopreventive Activity of Tamoxifen, <em>N</em>-(4-Hydroxyphenyl)retinamide, and the Vitamin D Analogue Ro24-5531 for Androgen-promoted Carcinomas of the Rat Seminal Vesicle and Prostate
Open the PDF for Chemopreventive Activity of Tamoxifen, <em>N</em>-(4-Hydroxyphenyl)retinamide, and the Vitamin D Analogue Ro24-5531 for Androgen-promoted Carcinomas of the Rat Seminal Vesicle and Prostate in another window
Journal Articles

The Human Prostatic Carcinoma Cell Line LNCaP Expresses Biologically Active, Specific Receptors for 1α,25-Dihydroxyvitamin D3

Gary J. Miller, Gary E. Stapleton, Janet A. Ferrara, M. Scott Lucia, Stephen Pfister, Tammy E. Hedlund, Prakash Upadhya
Journal: Cancer Research
Cancer Res (1992) 52 (3): 515–520.
Published: 01 February 1992
View article titled, The Human Prostatic Carcinoma Cell Line LNCaP Expresses Biologically Active, Specific Receptors for 1α,25-Dihydroxyvitamin D<sub>3</sub>
Open the PDF for The Human Prostatic Carcinoma Cell Line LNCaP Expresses Biologically Active, Specific Receptors for 1α,25-Dihydroxyvitamin D<sub>3</sub> in another window